Cingulate Research Development from 2010 to 2026

CING Stock  USD 5.74  0.02  0.35%   
Cingulate's Research Development is increasing over the last several years with slightly volatile swings. Research Development is predicted to flatten to about 10.4 M. During the period from 2010 to 2026 Cingulate Research Development regressed destribution of quarterly values had coefficient of variationof  20.77 and r-value of  0.29. View All Fundamentals
 
Research Development  
First Reported
2020-03-31
Previous Quarter
2.7 B
Current Value
2.8 M
Quarterly Volatility
727.5 M
 
Covid
 
Interest Hikes
Check Cingulate financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cingulate's main balance sheet or income statement drivers, such as Net Interest Income of 93.8 K, Depreciation And Amortization of 634.3 K or Interest Expense of 208.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.75. Cingulate financial statements analysis is a perfect complement when working with Cingulate Valuation or Volatility modules.
  
Build AI portfolio with Cingulate Stock
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
The Research Development trend for Cingulate offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cingulate is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Cingulate's Research Development Growth Pattern

Below is the plot of the Research Development of Cingulate over the last few years. It is Cingulate's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cingulate's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Cingulate Research Development Regression Statistics

Arithmetic Mean9,388,954
Geometric Mean9,207,721
Coefficient Of Variation20.77
Mean Deviation1,012,834
Median9,094,826
Standard Deviation1,949,645
Sample Variance3.8T
Range10.4M
R-Value0.29
Mean Square Error3.7T
R-Squared0.09
Significance0.25
Slope113,154
Total Sum of Squares60.8T

Cingulate Research Development History

202610.4 M
202510.9 M
20249.4 M
202315.5 M
2022M
20218.4 M
20205.1 M

About Cingulate Financial Statements

Cingulate stakeholders use historical fundamental indicators, such as Cingulate's Research Development, to determine how well the company is positioned to perform in the future. Although Cingulate investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cingulate's assets and liabilities are reflected in the revenues and expenses on Cingulate's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cingulate. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development10.9 M10.4 M

Currently Active Assets on Macroaxis

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Can Biotechnology industry sustain growth momentum? Does Cingulate have expansion opportunities? Factors like these will boost the valuation of Cingulate. Projected growth potential of Cingulate fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Cingulate demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(2.77)
Return On Assets
(1.07)
Return On Equity
(2.76)
Understanding Cingulate requires distinguishing between market price and book value, where the latter reflects Cingulate's accounting equity. The concept of intrinsic value—what Cingulate's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Cingulate's price substantially above or below its fundamental value.
It's important to distinguish between Cingulate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cingulate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cingulate's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.